See all Best Diagnostics Stocks 2026

IQVIA (IQV) Stock: Buy, Sell, or Hold?

IQV - IQVIA Holdings Inc.

SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
$261.77
4.47 (1.74%) ▲
5d: -3.63%
30d: +8.3%
90d: +44.58%
WAIT
LOW Confidence
Protect Your IQV Gains
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Oct 27, 2026
Smart Money Accumulation

Options open interest is building while the stock consolidates - a pattern consistent with institutional accumulation. View Scanner →

Signal fired Sep 8, 2026 at $263.91 · last confirmed Sep 9, 2026

Strength: 6.6/10

Get Alerted When IQV Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading historical data...

💡
Bottom Line:
ℹī¸ NEUTRAL: IQV is fairly priced but lacks strong directional signals. At 7.6% expected growth, valuation appears stretched. Wait for clearer setup or better entry on dips.
See Forward Earnings Fair Value & Price Prediction →

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$304.05
Based on 7.8% avg growth
INTRINSIC VALUE TODAY
$188.79
Trading above historical range

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 14.5x Exit PE.

View Full DCF Model

In-depth Analysis How we analyze

Valuation Analysis: IQV is currently trading at $261.77, which is considered slightly high relative to its 30-day fair value range of $239.17 to $263.19. From a valuation perspective, the stock is trading at a premium (Forward PE: 18.1) compared to its historical average (14.5). At these levels, the market is pricing in 7.6% annual earnings growth.

Technical Outlook: Technically, IQV is in a strong uptrend. Immediate support is located at $252.53, while resistance sits at $271.80.

Market Sentiment: IQV scores 30/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position SLIGHTLY HIGH
Historical Trading Range $239.17 - $263.19
Company Quality Score 44/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 41.4%

Protect Your Profits

Holding IQV? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

  • BEARISH: Weak technical setup (30/100)
  • BULLISH: High volume confirmation
  • NEUTRAL: Near Wall St target ($276.28)
  • BULLISH: Expecting earnings turnaround to 7.6% growth with 8.7% revenue growth
  • WARNING: Composite score 44/100 in the bottom quintile — this cohort historically lags the market

Trading Range Analysis

30-Day Trading Range $239.17 - $263.19
Current vs Trading Range SLIGHTLY HIGH

Support & Resistance Levels

Support Level $252.53
Resistance Level $271.80
Current Trend Strong Uptrend
Technical data as of Sep 11, 2026

Fundamental Context

Forward P/E (Next Year Est.) 18.10
Wall Street Target $276.28 (+5.5%)
Revenue Growth (YoY) 8.7%
Earnings Growth (YoY) -0.6%
Profit Margin 8.1%
Valuation Premium vs History +7.6% premium
PE vs Historical 18.1 vs 14.5 STRETCHED
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): +7.6% (market-implied from PE analysis)
1-Year Target $281.66 (+8%)
2-Year Target $303.07 (+16%)
3-Year Target $326.10 (+25%)
3-Yr Target (if PE normalizes) (PE: 18→15) PE COMPRESSION $261.19 (0%)
Earnings growth offset by PE compression
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 20.2, Growth: 11.5%) $404.56 (+55%)
Base: (SPY PE: 18.1, Growth: 11.5%) $363.11 (+39%)
Bear: (PE: 14.5, Growth: 11.5%) $290.83 (+11%)
📈 Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (32x PE), but valuation improves significantly next year (18x PE) as earnings recover.
Trailing PE: 32.22 | Current EPS (TTM): $8.03
Bull Case $512.47 (+96%)
Analyst growth 80.1%, PE expands to 35.4
Base Case $465.88 (+78%)
Market implied 80.1%, PE stable at 32.2
Bear Case $175.93 (-33%)
Severe decline -20.0%, PE contracts to 27.4
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: September 12, 2026 1:35 AM ET
Data refreshes hourly during market hours. Next update: 2:35 AM
đŸ”Ĩ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
See Full Scanner Results »
Technical Signals Check

Is IQV showing a specific setup today?

RSI Divergence Check TTM Squeeze Check MACD Crossover Check Gamma Walls Check Unusual Activity Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for IQV.

Create Free Account

Already have an account? Log In

Top Rated Diagnostics & Research Stocks

Top-rated stocks in Diagnostics & Research by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
TMO
Thermo Fisher Scientificâ€Ļ 		STRONG BUY
31 analysts 		$638 51 HOLD
EXAS
EXACT Sciences Corporatiâ€Ļ 		STRONG BUY
26 analysts 		$106 52 HOLD
DHR
Danaher Corporation 		STRONG BUY
25 analysts 		$229 49 HOLD
GH
Guardant Health Inc 		STRONG BUY
23 analysts 		$194 49 HOLD
NTRA
Natera Inc 		STRONG BUY
21 analysts 		$338 47 HOLD
TMO Thermo Fisher Sciâ€Ļ
51 HOLD
EXAS EXACT Sciences Coâ€Ļ
52 HOLD
DHR Danaher Corporatiâ€Ļ
49 HOLD
GH Guardant Health Iâ€Ļ
49 HOLD
NTRA Natera Inc
47 HOLD

Advanced IQV Option Strategies

Professional options setups generated by AI based on today's IQV price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for IQV

IQV Technical Chart IQV Price Prediction IQV Earnings Date IQV Investment Advisor IQV Fair Price Analyzer IQV Options Advisor IQV Options Chain IQV Options Analysis IQV Competitors
Compare IQV with Peers
IQV vs MTD
Which one to buy?
IQV vs FTV
Which one to buy?
IQV vs COO
Which one to buy?
IQV vs TFX
Which one to buy?
IQV vs CRL
Which one to buy?
IQV vs A
Winner: A
IQV vs MXCT
MTD vs IQV
Winner: MTD
IQV vs INCY
IDXX vs IQV
ONMD vs IQV
Winner: IQV
WAT vs IQV
TMO vs IQV
NTRA vs IQV
ILMN vs IQV
Winner: ILMN
Create New Comparison View All Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals